UK prostate cancer patients denied life-preserving focal therapy
Thousands of UK men with prostate cancer are reportedly being denied focal therapy, a non-invasive treatment that preserves quality of life by reducing side effects like erectile dysfunction and incontinence; despite three principal forms (HIFU, cryotherapy, NanoKnife) being available, the NHS offers access at only a few centres and doctors say patients aren’t routinely informed about this option, prompting calls for broader access amid supportive trial data and NICE approvals.
